Cargando…

Local High-Dose Radiotherapy Induces Systemic Immunomodulating Effects of Potential Therapeutic Relevance in Oligometastatic Breast Cancer

Local irradiation of cancer through radiotherapy can induce spontaneous regression of non-directly irradiated lesions, suggesting the involvement of systemic antitumor immune responses. In oligometastatic breast cancer (BC) patients, the use of stereotactic body radiotherapy (SBRT) favors the local...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muraro, Elena, Furlan, Carlo, Avanzo, Michele, Martorelli, Debora, Comaro, Elisa, Rizzo, Aurora, Fae’, Damiana A., Berretta, Massimiliano, Militello, Loredana, Del Conte, Alessandro, Spazzapan, Simon, Dolcetti, Riccardo, Trovo’, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681493/ https://www.ncbi.nlm.nih.gov/pubmed/29163540 http://dx.doi.org/10.3389/fimmu.2017.01476

Ejemplares similares

Improved Natural Killer cell activity and retained anti-tumor CD8(+) T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy
por: Muraro, E, et al.
Publicado: (2015)

Exploiting the Interplay between Innate and Adaptive Immunity to Improve Immunotherapeutic Strategies for Epstein-Barr-Virus-Driven Disorders
por: Martorelli, Debora, et al.
Publicado: (2012)

Seven fractions to deliver partial breast irradiation: the toxicity is Low
por: Trovo, Marco, et al.
Publicado: (2017)

Anthracycline-free neoadjuvant therapy induces pathological complete responses by exploiting immune proficiency in HER2+ breast cancer patients
por: Miolo, Gianmaria, et al.
Publicado: (2014)

A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies
por: Muraro, Elena, et al.
Publicado: (2011)

A BARF1-specific mAb as a new immunotherapeutic tool for the management of EBV-related tumors
por: Turrini, Riccardo, et al.
Publicado: (2017)

Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4(+) T Cells
por: Muraro, Elena, et al.
Publicado: (2017)

Clinical relevance of the combined analysis of circulating tumor cells and anti-tumor T-cell immunity in metastatic breast cancer patients
por: Muraro, Elena, et al.
Publicado: (2022)

Dissecting the Multiplicity of Immune Effects of Immunosuppressive Drugs to Better Predict the Risk of de novo Malignancies in Solid Organ Transplant Patients
por: Cangemi, Michela, et al.
Publicado: (2019)

Stereotactic ablative radiotherapy for oligometastatic prostate cancer
por: Gallizia, Elena, et al.
Publicado: (2022)

Radiotherapy for Oligometastatic Lung Cancer
por: Bergsma, Derek P., et al.
Publicado: (2017)

Stereotactic Ablative Radiotherapy for Oligometastatic Disease in Liver
por: Kim, Myungsoo, et al.
Publicado: (2014)

Phospholipid scramblase 1 as a critical node at the crossroad between autophagy and apoptosis in mantle cell lymphoma
por: Mastorci, Katy, et al.
Publicado: (2016)

Can the addition of radiotherapy postoperatively increase clinical outcome of patients with gastric cancer? A systematic review of the literature and meta-analysis
por: Fiorica, Francesco, et al.
Publicado: (2017)

High serum levels of soluble CD40-L in patients with undifferentiated nasopharyngeal carcinoma: pathogenic and clinical relevance
por: Caggiari, Laura, et al.
Publicado: (2007)

Radiotherapy of oligometastatic prostate cancer: a systematic review
por: Rogowski, Paul, et al.
Publicado: (2021)

Role of radiotherapy in oligometastatic breast cancer: Review of the literature
por: Beduk Esen, Caglayan Selenge, et al.
Publicado: (2022)

KIR-HLA Functional Repertoire Influences Trastuzumab Efficiency in Patients With HER2-Positive Breast Cancer
por: Muraro, Elena, et al.
Publicado: (2022)

Treatment of Oligometastatic Disease in Squamous Cell Carcinoma of the Head and Neck
por: Vincent, Aurora G., et al.
Publicado: (2020)

Virologic and Immunologic Evidence Supporting an Association between HHV-6 and Hashimoto's Thyroiditis
por: Caselli, Elisabetta, et al.
Publicado: (2012)

Toll-Like Receptor 1/2 and 5 Ligands Enhance the Expression of Cyclin D1 and D3 and Induce Proliferation in Mantle Cell Lymphoma
por: Mastorci, Katy, et al.
Publicado: (2016)

Oligometastatic Prostate Cancer
por: Stevens, Daniel J., et al.
Publicado: (2016)

Imaging of Oligometastatic Disease
por: Vietti Violi, Naik, et al.
Publicado: (2022)

Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
por: Decaestecker, Karel, et al.
Publicado: (2014)

Role of Radiosurgery/Stereotactic Radiotherapy in Oligometastatic Disease: Brain Oligometastases
por: Mazzola, Rosario, et al.
Publicado: (2019)

Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview
por: Zeng, Kang Liang, et al.
Publicado: (2019)

Extracranial Stereotactic Body Radiotherapy in Oligometastatic or Oligoprogressive Breast Cancer
por: Weykamp, Fabian, et al.
Publicado: (2020)

Stereotactic body radiotherapy for bone oligometastatic disease in prostate cancer
por: Patel, Priyanka H., et al.
Publicado: (2019)

Metastasis-Directed Radiotherapy for Oligometastatic Castration-Resistant Prostate Cancer
por: Katano, Atsuto, et al.
Publicado: (2021)

Proton Radiotherapy for Patients With Oligometastatic Breast Cancer Involving the Sternum
por: Johnson, Andrew, et al.
Publicado: (2021)

Stereotactic ablative radiotherapy for oligometastatic breast cancer in elderly patients
por: Morales-Orue, Ignacio, et al.
Publicado: (2020)

Radiotherapy is the Preferred Primary Tumor Treatment in Oligometastatic Prostate Cancer
por: van Moorselaar, R. Jeroen A., et al.
Publicado: (2022)

Stereotactic body radiotherapy for recurrent and oligometastatic soft tissue sarcoma
por: Feng, Xiao-Yao, et al.
Publicado: (2022)

Efficacy and Safety of Local Radiotherapy to All Oligometastatic Sites in Elderly Patients with Metachronous Oligometastatic Cancers After Initial Treatment for the Primary Tumor
por: Hu, Xiaolong, et al.
Publicado: (2021)

The biology and treatment of oligometastatic cancer
por: Reyes, Diane K., et al.
Publicado: (2015)

Highlights on the Management of Oligometastatic Disease
por: Alshehri, Salem M., et al.
Publicado: (2020)

Hypofractionated radiotherapy for primary or secondary oligometastatic lung cancer using Tomotherapy
por: Chang, Heng-Jui, et al.
Publicado: (2012)

Local ablative radiotherapy for oligometastatic non-small cell lung cancer
por: Suh, Yang-Gun, et al.
Publicado: (2019)

CyberKnife Stereotactic Ablative Radiotherapy for Recurrent or Oligometastatic Gynecological Cancers
por: Kataria, Tejinder, et al.
Publicado: (2021)

Stereotactic Radiotherapy in the Treatment of Paraneoplastic Vasculitis in Oligometastatic Renal Cell Carcinoma
por: Burgess, Laura, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bih9imdfsf04ra07psgu8p1gld